Beam Therapeutics Inc.

NASDAQ:BEAM

27.06 (USD) • At close November 8, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2023202220212020201920182017
Operating Activities:
Net Income -132.527-289.088-370.638-194.592-78.326-116.738-8.002
Depreciation & Amortization 20.01214.1477.4514.7353.5030.650.011
Deferred Income Tax -146.3950-16.76563.5184.4811.7490.5
Stock Based Compensation 98.64784.32143.5715.387.0287.0020.198
Change In Working Capital -116.455251.628111.2545.347-10.70510.0750.74
Accounts Receivables -0.146300-3000000
Inventory 0-3003000000
Accounts Payables -7.5782.3730.8180.064.0922.4360.726
Other Working Capital -108.731249.255110.4365.287-14.7977.6390.014
Other Non Cash Items 127.523-38.481158.869.8712.01766.9643.846
Operating Cash Flow -149.19522.527-66.268-95.741-72.003-20.298-2.707
Investing Activities:
Investments In Property Plant And Equipment -33.732-48.951-46.811-16.357-12.518-13.124-0.346
Acquisitions Net -105.572412.3850.6283.76654.14100
Purchases Of Investments -984.338-1,616.999-777.223-282.362-130.21-0.30
Sales Maturities Of Investments 1,089.911,204.614529.27198.59676.06900
Other Investing Activites 105.572-412.385-247.953-83.766-54.141-0.30
Investing Cash Flow 71.84-461.336-294.144-100.123-66.659-13.424-0.346
Financing Activities:
Debt Repayment -2.252-2.287-2.118-1.698-0.46400
Common Stock Issued 278.7108.258757.449320.62437.901179.7274.984
Common Stock Repurchased 0000-25.18700
Dividends Paid 0000-12.71400
Other Financing Activities -0.6315.6190.81320.62441.743179.7274.984
Financing Cash Flow 276.448111.59756.141322.32241.279179.7274.984
Other Information:
Effect Of Forex Changes On Cash -197.69000000
Net Change In Cash 203.128-327.219395.729126.458-97.383146.0051.931
Cash At End Of Period 435.895245.521572.74177.01150.553147.9361.931